Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2019-07-31 2019-07-31
Drug Identification Number 02458055 02458055
Brand name VENCLEXTA VENCLEXTA
Common or Proper name Venclexta 100mg unit dose Venclexta 100mg unit dose
Company Name ABBVIE CORPORATION ABBVIE CORPORATION
Ingredients VENETOCLAX VENETOCLAX
Strength(s) 100MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 1 tablet blister 1 tablet blister
ATC code L01XX L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2019-05-14 2019-05-14
Actual start date 2019-05-14 2019-05-14
Estimated end date 2019-08-01 2019-08-01
Actual end date 2019-07-29 2019-07-29
Shortage status Resolved Resolved
Company comments To ensure continuity of supply across all jurisdictions, and to avoid unnecessary stockpiling, orders will be processed to supply minimal quantity required. This will ensure that we meet patient needs. To ensure continuity of supply across all jurisdictions, and to avoid unnecessary stockpiling, orders will be processed to supply minimal quantity required. This will ensure that we meet patient needs.
Health Canada comments